Graft-versus-host disease following living donor liver transplantation

Liver Transplantation

Volumn 10, Issue 3, 2004, Pages 460-464

  Soejima, Yuji ^a   Shimada, Mitsuo ^a   Suehiro, Taketoshi ^a   Hiroshige, Shoji ^a   Gondo, Hisashi ^a   Takami, Akiyoshi ^b   Yasue, Shizuka ^b   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS;

ADULT; ALCOHOL LIVER DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CADAVER DONOR; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DIARRHEA; FATALITY; FEVER; GASTROENTERITIS; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HLA TYPING; HOMOZYGOSITY; HUMAN; INCIDENCE; JAPAN; LABORATORY TEST; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MORBIDITY; MORTALITY; ORGAN DONOR; PNEUMONIA; PRIORITY JOURNAL; RASH; RECIPIENT; UNITED STATES;

FATAL OUTCOME; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED;

EID: 1642264164     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20101     Document Type: Article

References (20)

1. Habib N, Tanaka K. Living-related liver transplantation in adult recipients: A hypothesis. Clin Transplant 1995;9:31-34.
2. Shimada M, Shiotani S, Ninomiya M, Terashi T, Hiroshige S, Minagawa R, et al. Characteristics of liver grafts in living donor adult liver transplantation: Comparison between right and left lobe grafts. Arch Surg 2002;137:1174-1179.
3. Umesita K, Monden M. Registry report of Japanese Liver Transplantation Society, 2002. Abstract presented at the 20th annual meeting of Japanese liver transplantation society, Tokyo, Japan.
4. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991;324:667-674.
5. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FI, Neiman PE, et al. Bone marrow transplantation (first of two parts). N Engl J Med 1975;292:832-843.
6. Thomas E, Storb R, Clift RA, Fefer A, Johnson FI, Neiman PE, et al. Bone marrow transplantation (second of two parts). N Engl J Med 1975;292:895-902.
7. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, et al. Graft-versus-host disease after liver transplantation in humans: A report of four cases. Hepatology 1991;14:274-281.
8. Collins RH, Cooper B, Nikaein A, Klintmalm G, Fay JW. Graft-versus-host disease in a liver transplant recipient. Ann Intern Med 1992;116:391-392.
9. Au WY, Ma SK, Kwong YL, Ng IOL, Hawkins BR, Wan TS, et al. Graft-versus-host disease after liver transplantation: Documentation by fluorescent in situ hybridisation and human leukocyte antigen typing. Clin Transplant 2000;14:174-177.
10. Fuchimoto Y, Huang CA, Yamada K, Shimizu A, Kitamura H, Colvin RB, et al. Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest 2000;105: 1779-1789.
11. Redondo P, España A, Herrero I, Quiroga J, Cienfuegos JA, Azanza JR, Prieto J. Graft-versus-host disease after liver transplantation. J Am Acad Dermatol 1993;29:314-317.
12. Cattral MS, Langnas AN, Wisecarver JL, Harper JC, Rubocki RJ, Bynon JS, et al. Survival of graft-versus-host disease in a liver transplant recipient. Transplantation 1994;57:1271-1274.
13. Lehner F, Becker T, Sybrecht L, Luck R, Schwinzer R, Slateva K, et al. Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression. Transplantation 2002;73:307-310.
14. Thaler M, Shamiss A, Orgad S, Huszar M, Nussinovitch N, Meisel S, et al. The role of blood HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med 1989;321:25-28.
15. Thorogood J. Relationship between HLA compatibility and first liver allograft survival. Transplant Proc 1993;25:2655-2656.
16. Kruskall MS, Alper CA, Awdeh Z, Yunis EJ. HLA-homozygous donors and transfusion-associated graft-versus-host disease [letter]. N Engl J Med. 1990;322:1004-1007.
17. Ho K. Report from the 5th transfusion symposium of the Japanese Red Cross Society. Available at: http://sue2400.tripod.co.jp/4.htm#002. Accessed November 10, 2002.
18. Whitington PF, Rubin CM, Alonso EM, Mckeithan TW, Anastasi J, Hart J, Thistlethwaite JR. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor. Transplantation 1996;62:1516-1519.
19. Kiuchi T, Harada H, Matsukawa H, Kasahara M, Inomata Y, Uemoto S, et al. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation. Transpl Int 1998;11:S383-S384.
20. Jagetia R, Small W Jr, Stuart FP, Sherry R, Stuart J, Kanwar YS, Mittal BB. Local graft irradiation after failure of modern immunosuppression in acute cellular and vascular rejection. Int J Radiat Oncol Biol Phys 1996;36:907-911.